Has Control of Hypercholesterolemia and Hypertension in Type 1 Diabetes Improved Over Time?
Open Access
- 1 March 2005
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (3) , 521-526
- https://doi.org/10.2337/diacare.28.3.521
Abstract
OBJECTIVE—To determine the extent to which patients’ awareness, treatment, and control of hypertension and hypercholesterolemia have changed over time and to examine factors associated with awareness and treatment in a type 1 diabetes population. RESEARCH DESIGN AND METHODS—Data from six examinations conducted over 10 years from the Pittsburgh Epidemiology of Diabetes Complications Study, a prospective study of subjects with childhood-onset (40 years), the youngest subjects with hypercholesterolemia were least likely to be treated and controlled to goal levels. Older age and physician contact were correlates of awareness and treatment of hypertension at baseline, while presence of renal or coronary complications was also associated with awareness and treatment of both hypertension and hypercholesterolemia at the 10-year follow-up. CONCLUSIONS—There is a considerable treatment gap, particularly for hypercholesterolemia. Improved treatment of both hypertension and hypercholesterolemia are clearly needed, particularly hypercholesterolemia in younger age-groups who have not yet experienced long-term complications.Keywords
This publication has 25 references indexed in Scilit:
- Standards of Medical Care for Patients With Diabetes MellitusClinical Diabetes, 2002
- Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively11See Editorial by Steffes, p. 378Kidney International, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study.Diabetes Care, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of internal medicine (1960), 1993
- The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert PanelArchives of internal medicine (1960), 1988
- The hypertension detection and follow-up programPreventive Medicine, 1976